The transformative effect of immunotherapies on the treatment landscape of DLBCL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-10-10
Просмотров: 90
Описание:
In this video, Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, comments on the value of CAR T-cell therapy in treating diffuse large B-cell lymphoma (DLBCL), highlighting the durable remission rates that have been observed with CAR-T products, suggesting a potential for cure in a significant percentage of patients. Dr Lin notes that CAR T-cells are not the only novel immunotherapy available, and that other transformative options, such as bispecific antibodies and antibody-drug conjugates, are also being used and studied in this patient population. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: